The Biden administration will petition the Supreme Court to resolve the legal battle concerning the use of the abortion pill, mifepristone. After a federal appeals court placed restrictions on its use, Attorney General Merrick Garland stated that the Justice Department would be “seeking emergency relief from the Supreme Court to defend the FDA’s scientific judgment and protect Americans’ access to safe and effective reproductive care.” The U.S. 5th Circuit Court of Appeals allowed the drug to remain on the market but placed limitations on its usage, such as forbidding mail orders and retaining in-person visits with a qualified practitioner. The court also reduced the window for the drug’s administration from 70 to 49 days. However, federal laws of limitations make it difficult for anti-abortion groups to dispute the FDA’s over twenty-year-old approval of the medication. Fifty Democratic senators and 190 members of the House Democratic caucus have filed an amicus brief supporting the Biden administration’s appeal. Republican opposition to medication abortion may garner stronger support at the polls.